USFDA classifies Granules Pharma facility as Voluntary Action Indicated Ruchika Sharma4 April 2024 3:00 PM ISTHyderabad: Granules India has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the facility of...
Granules India posts marginal rise in Q3 profit Ruchika Sharma23 Jan 2024 3:27 PM ISTBengaluru: Drug maker Granules India reported a marginal rise in third-quarter profit, helped by easing raw material costs.The company’s...
Granules India bags USFDA nod for Pantoprazole Sodium Delayed Release Tablets Ruchika Sharma13 Dec 2023 12:08 PM ISTPantoprazole Sodium Delayed-Release Tablets are indicated for short-term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux...
Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma4 Dec 2023 1:30 PM ISTSildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...
Granules India posts 3.4 percent rise in Q2 revenue Ruchika Sharma11 Nov 2023 3:00 PM ISTBengaluru: Granules India reported a 3.4% rise in second-quarter revenue as the Paracetamol maker benefited from higher sales in North...
Granules India bags USFDA nod for Esomeprazole Magnesium Delayed Release Capsules for GERD symptoms Ruchika Sharma19 Oct 2023 11:31 AM ISTHyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application...
Granules India, NIPER ink pact to establish Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development Ruchika Sharma16 Oct 2023 12:15 PM ISTHyderabad: Granules India, a vertically integrated pharmaceutical company, and the esteemed National Institute of Pharmaceutical Education and...
Granules India bags USFDA nod for Losartan and Hydrochlorothiazide Tablets Ruchika Sharma1 Oct 2023 2:30 PM ISTHyderabad: Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...
Granules India receives approval from Brazilian Health Regulatory Agency Ruchika Sharma26 Aug 2023 10:00 AM ISTHyderabad: Granules India Limited has announced the receipt of the approval from Brazilian Health Regulatory Agency (ANVISA), for compliance...
Granules India Jeedimetla facility bags accreditation certificate of Foreign Drug Manufacturer from PMDA Ruchika Sharma25 Aug 2023 11:37 AM ISTHyderabad: Granules India Limited has announced that the company has received the Accreditation Certificate of Foreign Drug Manufacturer from...
Granules India reports 62.5 percent fall in Q1 profit Ruchika Sharma10 Aug 2023 1:30 PM ISTRevenue from operations fell 3.3% to 9.85 billion rupees.
USFDA nod to Granules India Metoprolol Succinate ER Tablets Ruchika Sharma9 Aug 2023 11:30 AM ISTTelangana: Granules India has announced that the US Food & Drug Administration (US FDA) has approved the Company’s Abbreviated New Drug...
